Envista Stock (NYSE:NVST)
Previous Close
$18.03
52W Range
$15.14 - $25.64
50D Avg
$20.03
200D Avg
$18.90
Market Cap
$3.22B
Avg Vol (3M)
$2.01M
Beta
1.31
Div Yield
-
NVST Company Profile
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions. The company is headquartered in Brea, California and currently employs 12,800 full-time employees. The firm provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. The firm operates through two segments: Specialty Products & Technologies, and Equipment & Consumables. Its Specialty Products & Technologies segment develops, manufactures and markets dental implant systems, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. Its Equipment & Consumables segment develops, manufactures and markets dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems; treatment units and other dental practice equipment; endodontic systems and related consumables; restorative materials and instruments, rotary burs, impression materials, bonding agents and cements and infection prevention products.
NVST Performance
Peer Comparison
Ticker | Company |
---|---|
MMSI | Merit Medical Systems, Inc. |
ATRC | AtriCure, Inc. |
ALC | Alcon Inc. |
RMD | ResMed Inc. |
ANGO | AngioDynamics, Inc. |
HAE | Haemonetics Corporation |
COO | The Cooper Companies, Inc. |
WST | West Pharmaceutical Services, Inc. |
AKYA | Akoya Biosciences, Inc. |
HOLX | Hologic, Inc. |
ICUI | ICU Medical, Inc. |
ATR | AptarGroup, Inc. |
TFX | Teleflex Incorporated |